Templar Nova, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-07.
Templar Nova, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 7, 2026. The filing reports $7M sold. Its industry group is Biotechnology. It names Xi Chen (General Counsel) (SEC Form D, October 7, 2026).
Sell to companies like Templar Nova, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-07 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Templar Nova, Inc.
Free to see. No signup.
More on the people and the money behind Templar Nova, Inc., from the filings we hold.
Biotechnology raises by companies based in Maryland, filed in October 2026, largest first.
Get an email when Templar Nova, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Templar Nova, Inc. raises, hires or launches. No email unless you switch it on.
Watch Templar Nova, Inc. →Get the full cited report on Templar Nova, Inc.
What the filing shows about Templar Nova, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Templar Nova, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $7M, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer.
Xi Chen is named as General Counsel on the Form D that Templar Nova, Inc. filed with the SEC on 7 October 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-10-07 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Templar Nova, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Templar Nova, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Templar Nova, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Templar Nova, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Templar Nova, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Templar Nova, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-10-05 · Biotech raises in Washington, DC
https://mentionfox.com/funding/templar-nova-inc-form-d-000001